StapleBio

Kumamoto, Japan

StapleBio is a bio-tech company that focuses on the research and development of pharmaceuticals based on staple nucleic acid technology.

$3.0M raised

Apr 2024

Venture - Series Unknown

Biotechnology Life Science Pharmaceutical Product Design

Top Investors

Mitsubishi UFJ CapitalHigin CapitalTaiho PharmaceuticalSummit Pharmaceuticals InternationalDiamond Medino Capital

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about StapleBio

How much funding has StapleBio raised?

StapleBio has raised $3.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2024.

Who are StapleBio's investors?

StapleBio's investors include Mitsubishi UFJ Capital, Higin Capital, Taiho Pharmaceutical, Summit Pharmaceuticals International, Diamond Medino Capital.

Where is StapleBio headquartered?

StapleBio is headquartered in Kumamoto, Japan.

What does StapleBio do?

StapleBio is a bio-tech company that focuses on the research and development of pharmaceuticals based on staple nucleic acid technology.

What stage is StapleBio at?

StapleBio is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 1, 2024.

MLA

"StapleBio — Funding & Investors." VCBacked, April 1, 2024, https://www.vcbacked.co/company/staplebio. Accessed July 1, 2026.

APA

VCBacked. (2024). StapleBio — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/staplebio

Wikipedia (cite web)

{{cite web |title=StapleBio — Funding & Investors |url=https://www.vcbacked.co/company/staplebio |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 1, 2024.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K